Ειδήσεις: BIOGEN | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

01/04 22:11 bloomberg.com

Biogen Buys Apellis for $5.6B to Expand Kidney Drugs

Biogen Apellis kidney disease complement inhibitor $5.6B acquisition renal therapeutics

01/04 12:12 defenseworld.net

Burns Matteson Capital Management LLC Makes New Investment in Biogen Inc. $BIIB

Biogen hedge fund Burns Matteson investment biotechnology 13F filing

01/04 11:18 defenseworld.net

Econ Financial Services Corp Acquires New Position in Biogen Inc. $BIIB

Biogen Econ Financial Services 13F filing Biotechnology Investor activity Share acquisition

31/03 16:27 statnews.com

STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more

pharma drug launches Europe U.S. pricing policy Lilly Biogen

31/03 15:40 statnews.com

STAT+: Psychedelic biotechs face scrutiny over YouTube promos

psychedelic biotechs YouTube promotions regulatory scrutiny pharma acquisitions Eli Lilly Biogen

31/03 15:07 marketwatch.com

Biogen will acquire a drug company for $5.6 billion to expand work in kidney diseases

Biogen Apellis kidney disease drug acquisition biotechnology $5.6 billion

31/03 14:47 statnews.com

STAT+: Biogen to acquire immunology biotech Apellis for $5.6 billion

Biogen Apellis acquisition immunology macular degeneration Syfovre

30/03 16:34 statnews.com

STAT+: Biogen lupus drug improves skin clearance in mid-stage study

Biogen lupus skin clearance Insilico Medicine Eli Lilly AI drug discovery

28/03 10:30 defenseworld.net

Generali Investments CEE investicni spolecnost a.s. Purchases 4,797 Shares of Biogen Inc. $BIIB

Generali Investments Biogen Inc 13F filing Q4 holdings Advisory Services Network biotech investment

28/03 10:30 defenseworld.net

Generali Investments CEE investicni spolecnost a.s. Purchases 4,797 Shares of Biogen Inc. $BIIB

Generali Investments Biogen Inc 13F filing Q4 holdings Advisory Services Network biotech investment

Loading...